NCT03253107View on ClinicalTrials.gov

Predicting Biomarker of Gastric Cancer Chemotherapy Response

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Gastric CancerChemotherapy EffectPredictive Cancer Model
Interventions
DRUG

Chemotherapy

"Institutinal standard chemotherapy as first line~: XP (xeloda + cisplantin) or Xelox (xeloda+oxaliplitan) +/- Herceptin"

Trial Locations (1)

41404

RECRUITING

Kyungpook National University Medical Canter, Daegu

All Listed Sponsors
lead

Kyungpook National University Hospital

OTHER